Pharmaceuticals Machinery Market Size & Share 2025 – 2034

Pharmaceuticals Machinery Market Size

The global pharmaceuticals machinery market size was valued at USD 25.2 billion in 2024 and is estimated to grow at a CAGR of over 6.4% from 2025 to 2034, fueled by the growth of the biopharma market, increased regulations, improved technology, an increased production of generic drugs, and the larger manufacture of vaccines and injectables. Furthermore, the increasing population is estimated to further increase the demand for pharmaceuticals, especially for developing nations.

To get key market trends

Download Free PDF

These tools include technology such as automation, artificial intelligence (AI), and robotics among others which are improving effectiveness, precision and scalability in pharmaceutical manufacturing processes. These innovations facilitate regulatory compliance, decrease human errors, and improve productivity to meet the demand for new machinery. It is also important to note that biologics, vaccines, and biosimilars require certain kinds of equipment for example fill-finish systems and sterile processing systems, hence this is an important area for growth. In addition, CMOs and CDMOs are purchasing new machinery and equipment to facilitate warehousing and production of multiple pharmaceutical companies on demand.

Pharmaceuticals Machinery Market Trends

• It is noted that errors can be cut and efficiency boosted when automation is integrated across the production process in pharmaceutical industries, production capacity is increased at the same time. Accurate automated systems enhance the precision of tasks completed significantly leading to better productivity and consistency over time.
   
• The increased production of biologics and biosimilars ‘is raising the need for a variety of specialized equipment such as lyophilizers, fill-finish systems, and fermentation units. Moreover, Medicine tailored to the individual is raising the demand for equipment and machinery that can be quickly adapted for small-sized batches with a variety of formulations and dosages.
   

Pharmaceuticals Machinery Market Analysis

Complexity in operations, high set costs at the beginning, regulatory barriers, issues within the supply chains, environmental factors, and many others are among the challenges that the pharmaceuticals machinery industry has to deal with while looking for growth. Machinery for the pharmaceutical industry can be prohibitively expensive. This can hinder the ability for medium and small-sized companies to expand their manufacturing output. Currency depreciation is another factor that raises the price of equipment.
 

Furthermore, skill shortages in an area can exacerbate issues that stem from the lack of trained operators that are needed to run the machinery. Energy consumption health concerns are growing, and many countries are imposing strict policies on environmentally harmful practices to become more sustainable. In light of these policy decisions, manufacturers have shifted towards energy-efficient machines; however, this transition has resulted in increased costs which can affect global competitiveness.
 

• The pharmaceuticals machinery market from solid dosage machine segment surpassed USD 9.6 billion in 2024, and it is presumed that the CAGR from the years 2025-2034 will be around 6.8% fictional Research Program. In line with the increase in sophistication and versatility of tools available to manufacture solids in the shape of tablets powder or capsule, the `price and reliability’ of the end product becomes the focus of user alongside the rate of production.
   
• In addition, processing equipment is essential for the production of medications. Specialists assert that due to the expansion of biosimilars and biologics, there has been a severe need for complex biology-based devices like fermentation tanks, mixers, and dryers. Many of the processes are simplified during automation of pharmaceutical equipment which enhances the overall reliability and efficiency of the process.
   

Learn more about the key segments shaping this market

Download Free PDF

• The pharmaceuticals machinery market from fully automatic segment accounted held 61% share in 2024 and is expected to grow at a rate of 6.6% between 2025 and 2034. These fully automatic systems help in the high-volume manufacturing of pharmaceutical products such as tablets, capsules, and injectables.
   
• Such machines perform filling, capping, labeling, and packaging functions, thus enabling producers to effectively respond to an increasing market. Semi-automatic machines, on the other hand, are built for such applications that would require a slight manual intervention in some instances while keeping some elements out so as to increase both efficiency and the reduction of errors while ensuring 100% reliable quality. These are semi-automatic systems that serve the purposes of medium production and are very much in demand for small to medium size manufacturers since they add volume without the financial burden of fully automatic systems.
   

• The U.S. pharmaceuticals machinery market exceeded USD 5.7 billion in 2024 and a projected 6.5% CAGR through 2034, due to the increasing consumption of various pharmaceutical products, development in machinery, personalization and small-scale production, focus on biopharmaceuticals, and new innovation in vaccine production.
   
• The demand for medicines is on the rise due to more and more people suffering from chronic diseases and illnesses. The use of automated production equipment in the pharmaceutical industry has facilitated the decentralized production of medications for chronic illnesses, cancer, and infectious diseases. Moreover, the continued growth towards biopharmaceuticals, especially biologics and biosimilars which also incorporate fermentation, sterile filling and lyophilization, requires the use of specialized machinery. In addition, the penetration of Industry 4.0 technologies such as Automation and IoT in the healthcare sector is among the most powerful market growth factors. These technologies enable remote monitoring and predictive maintenance which have the effect of allowing greater pliability and shorter downtimes.
   

North America: As for the country, the United States holds first place with a total market share of nearly 79% in 2024. The increasing popularity of pharmaceutical services in the US along with the advances in technology, miniaturized and tailored production, the emphasis on biopharmaceuticals and the development of new methods of vaccine production makes the US pharmaceutical machinery market to be fast expanding.
 

Conversely, the Canadian market for pharmaceutical machinery is projected to expand at a compound annual growth rate of 5.1% during the period of 2025 to 2034. Such a trend can be attributed to the advanced Canadian pharmaceutical technology in the production of biologics and advanced biosimilars, which necessitate bioreactors, fermentation systems, sterile fill finish lines, clean rooms, and other technologies.
 

Europe: The European pharmaceuticals machinery market is accelerating at a compound annual growth rate of 5.8% from 2025 to 2034. In 2024, this narrow region was projected to account for approximately 23% of the global market share (US$122.8 billion). The high and growing healthcare expenditure in Europe is being driven by the rise in elderly people who require pharmaceuticals for chronic diseases, oncology, as well as Alzheimer’s and cardiovascular diseases. This has led to the manufacturers being prompted to spend on appropriately scaled and efficient durable medical equipment for pharmaceuticals and vertical and horizontal therapy machines for specialized areas.
 

Germany pharmaceuticals machinery market is expected to be at the forefront of the European medication’s technology Market booming at 6.7% between 2025-2034. Germany currently has Europe’s largest medication technology industry, ranked 4th globally with the strongest help from its combined industrial and external supply needs. Pharmaceutical firms headquartered in Germany are deploying AIM Pharma and Phi Group machines to enhance production in order to address forecast drug demands.
 

Asia Pacific: The Asia Pacific pharmaceutical machinery Industry is recovering and is set to achieve a market share of 39% in 2024 with an estimated CAGR rate of 7.1% between 2025 and 2034.
 

Asia Pacific appears to be the center for generic drug manufacturing, owing to reduced costs, high capacity for production and a proficient workforce. The upturn in the production process in India and China further increases the need for cost-effective pharmaceutical equipment.
 

When the nation is concerned, India has become the fastest evolving nation in terms of CAGR of 7.7% from 2025 to 2034. The pharmaceutical machinery market has been booming in India thanks to the to the development of novel biopharmaceuticals including vaccines and biosimilars which has increased the demand for working tools such as bioreactors, sterile fill-finish lines and cleanroom systems.
 

Pharmaceuticals Machinery Market Share

 In 2024, Bausch+Strobel, Fette Compacting, GEA, IMA and Syntegon Technology, amalgamated accounted for 20%-25% of the market. These businesses have been trying out different tactics, such as mergers and acquisitions, expanding their facilities, and working together on products, so that they can broaden their client base and enhance their market standing.


Manufacturing companies are now introducing equipment that is more advanced, automated and equipped with industry four point zero technological capabilities. Manufacturers are using AI for predictive maintenance and robotics for production efficiency promotion. A greater range of production machinery that allows a wider variety of small batch production and medicines which is made based on specific requirements is being sought. In highly niche markets, companies providing more customized, more adaptable solutions are winning market shares.
 

Pharmaceuticals Machinery Market Companies

Major players operating in the pharmaceuticals machinery industry are:

• ACG 
• Bausch+Strobel
• CECLE Machine
• Fette Compacting
• GEA
• Glatt
• IMA
• Korsch
• Paul Mueller
• RIVA
• Romaco
• SaintyCo 
• Sartorius
• SED Pharma
• Syntegon Technology 
   

Pharmaceuticals Machinery Industry News

• In June 2024, GEA Pharma & Healthcare introduced NexGen Press 45 which is a part of NexGen C series and advances in the tablet press line. As it can fulfill any Containment level of protection, this model is an improvement of the NexGen Press 30.
   
• Korsch America, which is a sub-sector of Korsch AG, advances on to unveil its flagship product, X 5 tablet press in March 2024, to the North American Market. The X 5 is able to deliver 50 percent more than the XL 400 while simultaneously being able to offer single sided output, which is a modest chunk. The strategy behind it is to enable an enhanced turret segment that increases punch stations resulting in greater single sided output without significantly altering the design structure.
   
• Further on in November of 2023, ACG was able to launch its advanced prototype of its capsule filling machine during CPHI and PMEC India. Its concentration on ease of use while providing great efficiency alongside heightened safety measures adds to its credibility by cutting down on maintenance costs and minimizing, if not eliminating, downtime.
   
• In August 2023, Sartorius and Repligen Corporation launched an integrated bioreactor system combining Repligen's XCell ATF technology with Sartorius’ Biostat STR bioreactor. The system simplifies seed train and N perfusion processes, featuring an embedded XCell ATF module with advanced control recipes and integrated Process Analytical Technology (PAT).
   

This pharmaceuticals machinery market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Billion) & volume (Thousand Units) from 2021 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Machine Type

• Solid dosage machine
  • Tablet press machine
    • Tablet press
    • Tablet dedusters
    • Others (tablet inspection etc.)
  • Capsule filling machine
    • Capsule polishers
    • Capsule separator
    • Others (capsule inspection etc.)
  • Others (softgel encapsulation etc.)
• Processing machine
  • Mixing
    • V blender
    • Cone blender
    • Others (IBC blender etc.)
  • Granulation
    • High shear granulator
    • Oscillating granulator
    • Others (comill etc.)
  • Fluid bed dryers
    • Lab fluid bed dryer
    • Others (production fluid bed dryer etc.)
  • Film coating
    • Lab film coating
    • Others (production film coating etc.)
• Analytical instruments
  • Pharmaceutical tablet testing
    • Tablet hardness tester
    • Tablet friability tester
    • Dissolution tester
    • Others (disintegration tester etc.)
  • Gelatin tester
    • Gelatin strength tester
    • Gelatin bloom strength
    • Others (gelatin transparency tester etc.)
• Packaging machine
  • Blister packers
  • Cappers
  • Cartoners
  • Induction sealers
  • Tube fillers
  • Others (counters etc.)
• Printing machine
• Others (material handling etc.)

Market, By Mode of Operation

• Manual
• Semi-automatic
• Fully automatic    

Market, By Application

• Formulation
• Filling & packaging
• Sterilization
• Quality control
• Others (storage etc.)     

Market, By Distribution Channel

• Direct sales
• Indirect sales   

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia 
• Latin America
  • Brazil
  • Mexico
• MEA
  • UAE
  • Saudi Arabia
  • South Africa